Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%. Market Analysis and Insights: Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market is valued at US$ 82 million in 2019. The market size will reach US$ 124.9 million by the end of 2026, growing at a CAGR of 6.1% during 2021-2026. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Scope and Market Size Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type 5-HT3 Inhibitors NK1 Inhibitors Other Segment by Application Highly Emetogenic Chemotherapy Moderately Emetogenic Chemotherapy Low Emetogenic Chemotherapy Other By Company Merck Eisai Mundipharma Qilu Pharma Teva Novartis Heron Therapeutics Roche Mylan Tesaro By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia
1 Study Coverage 1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Type 1.4.2 5-HT3 Inhibitors 1.4.3 NK1 Inhibitors 1.2.4 Other 1.3 Market by Application 1.3.1 Global Chemotherapy Induced Nausea and Vomitin
